The FDA has approved the first genetically modified animal for human consumption, the AquAdvantage salmon. What are the implications of this momentous decision? In this panel discussion, experts from diverse backgrounds will share their views on what's next for our oceans and our food supply. An attorney will discuss the potential risks to wild salmon populations, which are the basis of a lawsuit to block the approval. A fisherperson will share his perspective on genetically engineered salmon, and what may be in store for salmon lovers and the people whose livelihoods depend on the ocean. A scientist will talk about next-generation fish farming and the prospects for meeting the world's growing demand for seafood while maintaining the health of our fisheries. Now that the AquAdvantage salmon has been approved without a labeling requirement, what genetically engineered food animals may be on the horizon?
Panelists include: Hans Haveman, fisherman and owner of H and H Fresh Fish; Maggie Ostdahl, Sustainable Initiatives Manager for Aquarium of the Bay and coordinator of the San Francisco Bay Area Sustainable Seafood Alliance; and Adam Keats, Senior Attorney for Center for Food Safety, the organization filing suit to block the AquAdvantage approval.
January 13, 2016 6:00 PM-8:00 PM
Location: San Francisco Ferry Building Port Commission Hearing Room | One Ferry Building, San Francisco, CA 94111
Event website: cuesa.org